A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas Meeting Abstract


Authors: Gounder, M. M.; Loong, H. H. F.; Nyquist-Schultz, K.; Baker, S.; Ustoyev, Y.; Tanner, L. R.; Shacham, S.; McCauley, D.; Rashal, T.; Saint-Martin, J. R.; Shacham, E.; Friedlander, S.; Tamir, S.; Marshall, T.; Landesman, Y.; Kauffman, M.; Rebello, S.; Mirza, M. S. R.; Schwartz, G. K.; Razak, A. R. A.
Abstract Title: A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204720
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.10587
Notes: Meeting Abstract: 10587 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Mrinal M Gounder
    230 Gounder
  3. Lanier R Tanner
    4 Tanner